Josh Thomas Georgy

9PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical microbiology not elsewhere classifiedGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursForensic epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 24, 2025
Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non-Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score-Matched Analysis.

Praveen Kumar Marimuthu, Josh Thomas Georgy, Deepa Susan Joy Philip

|Oct 01, 2024
Metastatic Malignant Pseudomyogenic Hemangioendothelioma: An Exceedingly Rare Entity That Challenges Conventional Paradigms.

Zachariah Thomas, Josh Thomas Georgy, Madhurima Ponmar

|Jun 21, 2024
Randomized Placebo-Controlled Trial of Topical Capsaicin for Delayed Chemotherapy-Induced Nausea and Vomiting.

Heber Rew Bright, Ashish Singh, Anjana Joel

|Mar 28, 2024
The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South Indians.

Ajoy Oommen John, Ashish Singh, Pratibha Yadav

|Nov 01, 2023
Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer.

Ashish Singh, Josh Thomas Georgy, Anjana Joel

|Mar 22, 2022
Anemia requiring transfusion in breast cancer patients on dose-dense chemotherapy: Prevalence, risk factors, cost and effect on disease outcome.

Parth Sharma, Josh Thomas Georgy, Anand George Andrews

Pageof 2

Frequent Collaborators

4 joint publications

Anjana Joel

3 joint publications

Ajoy Oommen John

2 joint publications

Ashish Singh

1 joint publications

Parth Sharma